Blocking of Frizzled Signaling With a Homologous Peptide Fragment of Wnt3a/Wnt5a Reduces Infarct Expansion and Prevents the Development of Heart Failure After Myocardial Infarction

Hilde Laeremans, Tilman M. Hackeng, Marc A. M. J. van Zandvoort, Victor L. J. L. Thijssen, Ben J. A. Janssen, Harry C. J. Ottenheijm, Jos F. M. Smits, W. Matthijs Blankesteijn*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

97 Citations (Web of Science)
35 Downloads (Pure)


Background-The molecular pathways that control the wound healing after myocardial infarction (MI) are not completely elucidated. One of these pathways is the Wnt/Frizzled pathway. In this study, we evaluated Frizzled as a novel therapeutic target for MI. These Frizzled proteins act as receptors for Wnt proteins and were previously shown to be expressed in the healing infarct. Methods and Results-Wnt/Frizzled signaling has been studied for decades, but synthetic ligands that interfere with the interaction between Wnts and Frizzled have not been described to date. Here we report the selection of 3 peptides derived from regions of high homology between Wnt3a and Wnt5a that act as antagonists for Frizzled proteins. UM206, the peptide with the highest affinity, antagonized the effect of Wnt3a and Wnt5a in different in vitro assays. Administration of UM206 to mice for 5 weeks, starting immediately after the induction of MI, reduced infarct expansion and increased the numbers of capillaries and myofibroblasts in the infarct area. Moreover, heart failure development was inhibited by this therapy. Conclusions-Blocking of Frizzled signaling reduces infarct expansion and preserves cardiac function after MI. Our findings underscore the potential of Frizzled receptors as a target for pharmacotherapy of cardiac remodeling after MI. (Circulation. 2011; 124: 1626-1635.)
Original languageEnglish
Pages (from-to)1626-U107
Issue number15
Publication statusPublished - 11 Oct 2011


  • heart failure
  • myocardial infarction
  • myofibroblasts
  • pharmacology
  • receptor blocker
  • Wnt/frizzled pathway

Cite this